Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
182.87
-5.44 (-2.89%)
At close: Apr 28, 2026, 4:00 PM EDT
183.30
+0.43 (0.24%)
After-hours: Apr 28, 2026, 7:57 PM EDT
Insulet Employees
Insulet had 5,400 employees as of December 31, 2025. The number of employees increased by 1,500 or 38.46% compared to the previous year.
Employees
5,400
Change (1Y)
1,500
Growth (1Y)
38.46%
Revenue / Employee
$501,500
Profits / Employee
$45,759
Market Cap
12.67B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5,400 | 1,500 | 38.46% |
| Dec 31, 2024 | 3,900 | 900 | 30.00% |
| Dec 31, 2023 | 3,000 | 400 | 15.38% |
| Dec 31, 2022 | 2,600 | 300 | 13.04% |
| Dec 31, 2021 | 2,300 | 400 | 21.05% |
| Dec 31, 2020 | 1,900 | 550 | 40.74% |
| Dec 31, 2019 | 1,350 | 181 | 15.48% |
| Dec 31, 2018 | 1,169 | 312 | 36.41% |
| Dec 31, 2017 | 857 | 217 | 33.91% |
| Dec 31, 2016 | 640 | -7 | -1.08% |
| Dec 31, 2015 | 647 | 128 | 24.66% |
| Dec 31, 2014 | 519 | 41 | 8.58% |
| Dec 31, 2013 | 478 | -60 | -11.15% |
| Dec 31, 2012 | 538 | -38 | -6.60% |
| Dec 31, 2011 | 576 | 266 | 85.81% |
| Dec 31, 2010 | 310 | 34 | 12.32% |
| Dec 31, 2009 | 276 | -18 | -6.12% |
| Dec 31, 2008 | 294 | 47 | 19.03% |
| Dec 31, 2007 | 247 | -47 | -15.99% |
| Dec 31, 2006 | 294 | 47 | 19.03% |
| Dec 31, 2005 | 247 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Koninklijke Philips | 65,340 |
| STERIS | 17,787 |
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
| DexCom | 11,100 |
| Bio-Rad Laboratories | 7,450 |
| Bio-Rad Laboratories | 7,450 |
| Globus Medical | 6,000 |
PODD News
- 17 hours ago - Insulet to Participate in BofA Securities 2026 Health Care Conference - Business Wire
- 27 days ago - Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026 - Business Wire
- 4 weeks ago - Insulet Appoints Mike Panos as Chief Commercial Officer - Business Wire
- 4 weeks ago - PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm - Business Wire
- 6 weeks ago - Insulet recalls some insulin devices in US over leakage risk - Reuters
- 6 weeks ago - Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S. - Business Wire
- 6 weeks ago - Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes - Business Wire
- 7 weeks ago - Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) - Business Wire